{"symbol":"PFE","fiscalQuarter":"Q1-2022","reportDate":"2022-05-03","reportTime":"BMO","status":"reported","company":{"name":"Pfizer Inc.","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/PFE/earnings/Q1-2022","postBrief":{"headline":"Pfizer Misses on EPS, Stock Up 1.97%","keyNumbers":[{"metric":"EPS","actual":"$1.62","expected":"N/A","surprise":"-2.64%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted ongoing efforts in research and development.","They expressed confidence in future product pipelines despite current challenges."],"summary":"Management remains focused on innovation and long-term growth. They acknowledged current market pressures but emphasized their commitment to advancing their portfolio."},"guidanceChanges":{"summary":"No guidance updates were provided during the earnings call.","changes":[]},"whatItMeans":"Pfizer's earnings report shows a slight miss on EPS, which may raise concerns among investors. However, the stock reacted positively, increasing by 1.97%. This could indicate that investors are optimistic about the company's long-term prospects despite the EPS miss.","metaDescription":"Pfizer Inc (PFE) Q1 2022 earnings: EPS missed expectations. Stock up 1.97%. Full breakdown."}}